Wu J, Katrekar A, Honigberg LA, Smith AM, Conn MT, Tang J, et al. Identification of substrates of human protein-tyrosine phosphatase PTPN22. J Biol Chem. 2006;281:11002–10.
Article CAS PubMed Google Scholar
Kocher A. The treatment of hypothyroidism by thyroid transplantation. Br Med J. 1923;2:560–1.
Article CAS PubMed PubMed Central Google Scholar
Binti S, Linder AG, Edeen PT, Fay DS. A conserved protein tyrosine phosphatase, PTPN-22, functions in diverse developmental processes in C. elegans. PLoS Genet. 2024. https://doi.org/10.1371/journal.pgen.1011219.
Article PubMed PubMed Central Google Scholar
Brownlie RJ, Zamoyska R, Salmond RJ. Regulation of autoimmune and anti-tumour T-cell responses by PTPN22. Immunology. 2018;154:377–82.
Article CAS PubMed PubMed Central Google Scholar
Yu X, Sun JP, He Y, Guo X, Liu S, Zhou B, et al. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases. Proc Natl Acad Sci U S A. 2007;104:19767–72.
Article CAS PubMed PubMed Central Google Scholar
Ivashkiv LB. PTPN22 in autoimmunity: different cell and different way. Immunity. 2013;39:91–3.
Article CAS PubMed PubMed Central Google Scholar
Wang Y, Shaked I, Stanford SM, Zhou W, Curtsinger JM, Mikulski Z, et al. The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity. 2013;39:111–22.
Article CAS PubMed Google Scholar
Spalinger MR, Lang S, Vavricka SR, Fried M, Rogler G, Scharl M. Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagy. PLoS ONE. 2013;8:e72384.
Article CAS PubMed PubMed Central Google Scholar
Zhuang C, Yang S, Gonzalez CG, Ainsworth RI, Li S, Kobayashi MT, et al. A novel gain-of-function phosphorylation site modulates PTPN22 inhibition of TCR signaling. J Biol Chem. 2024;300:107393.
Article CAS PubMed PubMed Central Google Scholar
Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science. 2004;303:685–9.
Article CAS PubMed Google Scholar
Bai B, Li T, Zhao J, Zhao Y, Zhang X, Wang T, et al. The tyrosine phosphatase activity of PTPN22 is involved in T Cell development via the regulation of TCR expression. Int J Mol Sci. 2023. https://doi.org/10.3390/ijms241914505.
Article PubMed PubMed Central Google Scholar
Jassim BA, Lin J, Zhang ZY. PTPN22: structure, function, and developments in inhibitor discovery with applications for immunotherapy. Expert Opin Drug Discov. 2022;17:825–37.
Article CAS PubMed PubMed Central Google Scholar
Armitage LH, Wallet MA, Mathews CE. Influence of PTPN22 allotypes on innate and adaptive immune function in health and disease. Front Immunol. 2021. https://doi.org/10.3389/fimmu.2021.636618.
Article PubMed PubMed Central Google Scholar
Ho WJ, Croessmann S, Lin J, Phyo ZH, Charmsaz S, Danilova L, et al. Systemic inhibition of PTPN22 augments anticancer immunity. J Clin Invest. 2021. https://doi.org/10.1172/JCI146950.
Article PubMed PubMed Central Google Scholar
Ho WJ, Lin J, Danilova L, Phyo Z, Charmsaz S, Mohan A, et al. Abstract 3398: PTPN22 is a systemic target for augmenting antitumor immunity. Cancer Res. 2020;80:3398.
Budding K, van Setten J, van de Graaf EA, van Rossum OA, Kardol-Hoefnagel T, Kwakkel-van Erp JM, et al. The autoimmune-associated single nucleotide polymorphism within PTPN22 correlates with clinical outcome after lung transplantation. Front Immunol. 2019. https://doi.org/10.3389/fimmu.2018.03105.
Article PubMed PubMed Central Google Scholar
Beyza G, Ali OG. Tissue-specific immunity for transplantable endocrine glands in the context of HLA Expression. In: Sevim G, editor. Human Leukocyte Antigens Rijeka. NY: IntechOpen; 2023.
留言 (0)